Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02261649 · ClinicalTrials.gov registry record
Impact of Cerebellar Mass Resection on Pain Processing
A clinical trial, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- 24
- Enrollment target
NCT02261649 is a clinical trial that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 24 participants.
The verdict
NCT02261649 has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate how cerebellar resection surgery may affect pain sensation and the way the brain "reads" pain signals. By measuring brain activity in children and adolescents following surgery, the investigators hope to gain valuable information about pain processing in the brain.
Interventions
- OTHER Questionnaires
- DEVICE Medoc Advanced Medical Systems PATHWAY Model ATS
- PROCEDURE Cold water bath
- DEVICE MRI scanner
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2014-10 |
| Est. Completion | 2017-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02261649
The ClinicalTrials.gov registry entry for NCT02261649 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Questionnaires is the first listed.
NCT02261649 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02261649 about?
NCT02261649 is a clinical study titled "Impact of Cerebellar Mass Resection on Pain Processing". The purpose of the study is to evaluate how cerebellar resection surgery may affect pain sensation and the way the brain "reads" pain signals. By measuring brain activity in children and adolescents following surgery, the investigators hope to gain valuable information about pain processing in the b...
What is the current status of trial NCT02261649?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2014-10. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02261649?
The interventions under investigation include: Questionnaires (OTHER), Medoc Advanced Medical Systems PATHWAY Model ATS (DEVICE), Cold water bath (PROCEDURE), MRI scanner (DEVICE).
Who is sponsoring clinical trial NCT02261649?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.